---
schema_version: "secwatch.filing_event.v1"
accession: "0000021076-26-000008"
form_type: "8-K"
ticker: "CLX"
cik: "0000021076"
company_name: "CLOROX CO /DE/"
filed_at: "2026-02-03T23:59:59+00:00"
generated_at: "2026-05-16T05:26:59.226981+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Clorox Q2 FY2026 sales down 1% to $1.67B, EPS $1.29, reaffirms outlook

## Summary
- Net sales $1.67B (-1% YoY); organic sales -1%; gross margin 43.2% (-60 bps).
- Diluted EPS $1.29 (-16% YoY); adjusted EPS $1.39 (-10% YoY).
- YTD operating cash flow $404M (+1%); free cash flow $326M (10.5% of sales).
- Segment: Health & Wellness +2%, Household -6%, Lifestyle -5%, International +7%.
- CEO Linda Rendle reaffirms FY2026 outlook; cites recently announced GOJO acquisition.

## SEC filing metadata
- accession: 0000021076-26-000008
- form_type: 8-K
- ticker: CLX
- cik: 0000021076
- company_name: CLOROX CO /DE/
- filed_at: 2026-02-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/21076/000002107626000008/0000021076-26-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/21076/000002107626000008/clx-20260203.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000021076-26-000008
- JSON: https://secwatch.observer/filing/0000021076-26-000008.json
- Plain text: https://secwatch.observer/filing/0000021076-26-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.